AMLX EBITDA Margin
Amylyx Pharmaceuticals Inc · EBITDA Margin
AMLX EBITDA Margin
Latest reported22457.14%period ending
AMLX TTM EBITDA Margin (-53186.38% → 22457.14%)
TTM ebitda margin
High-resolution chart · PNG
AMLX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 22,457.1429% | |
| 75,324.0964% | |
| 17,197.0912% | |
| -344.7734% | |
| -130.5107% | |
| -53.9687% | |
| -16.1954% | |
| 14.5449% | |
| 2.2653% | |
| -36.3593% | |
| -157.8509% | |
| -886.7027% | |
| -53,186.3768% |